3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Cardiotoxicity
4
Sarcoma
3
Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Interventions
Cytarabine
52
Methotrexate
33
Cyclophosphamide
33
Daunorubicin
29
Gene Expression Profiling
27
Flow Cytometry
23
Vincristine
22
Mercaptopurine
19
Dexamethasone
19
Asparaginase
19
Filgrastim
18
Microarray Analysis
16
Etoposide
16
Radiotherapy
15
Thioguanine
14
Prednisone
14
Leucovorin
14
Idarubicin
13
Polymerase Chain Reaction
12
Peripheral Blood Stem Cell Transplantation
12
Gemtuzumab
12
Doxorubicin
12
pegaspargase
10
Hydrocortisone
10
Calcium Dobesilate
10
Busulfan
10
Reverse Transcriptase Polymerase Chain Reaction
9
Mitoxantrone
9
Granulocyte Colony-Stimulating Factor
9
Cytogenetic Analysis
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Leukemia
×
Dexrazoxane
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled